Paggiarino Dario A. — SEC Form 4 filings

SEC reporting owner CIK 1574261. 7 Form 4 filings on record with FilingPulse; latest filed 2024-04-02.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-01-09 to 2024-04-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
EyePoint Pharmaceuticals, Inc. (EYPT)Chief Medical Officer710 legs · 89,224 sh · $2,174,45340

Form 4 filings — Paggiarino Dario A.

FiledFormIssuerReported transactionsSource
2024-04-024EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 5,834 @ $0 · Option exercise (M): 30,570 @ $0 · Option exercise (M): 14,000 @ $0 · Tax withholding (F): 15,493 @ $20.67 · Tax withholding (F): 2,957 @ $20.67 · Tax withholding (F): 7,096 @ $20.67 · +3 moreEDGAR
2024-02-134EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 4,967 @ $0 · Option exercise (M): 5,833 @ $0 · Tax withholding (F): 2,518 @ $28.80 · Tax withholding (F): 2,565 @ $28.80 · Option exercise (M): 4,967 (derivative) @ $0 · Option exercise (M): 5,833 (derivative) @ $0EDGAR
2024-01-304EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 15,609 @ $12.90 · Option exercise (M): 51 @ $13.13 · Option exercise (M): 33,665 @ $13.13 · Sale (S): 51 @ $25.41 · Sale (S): 15,609 @ $25.41 · Sale (S): 33,665 @ $25.77 · +3 moreEDGAR
2024-01-294EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 300 @ $13.13 · Option exercise (M): 300 @ $12.90 · Sale (S): 300 @ $25 · Sale (S): 300 @ $25 · Option exercise (M): 300 (derivative) @ $0 · Option exercise (M): 300 (derivative) @ $0EDGAR
2024-01-254EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 3,096 @ $13.13 · Option exercise (M): 2,039 @ $12.90 · Sale (S): 2,039 @ $25 · Sale (S): 3,096 @ $25 · Option exercise (M): 5,651 @ $12.90 · Option exercise (M): 5,600 @ $13.13 · +6 moreEDGAR
2024-01-104EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 22,913 @ $3.26 · Sale (S): 22,913 @ $21.13 · Option exercise (M): 22,913 (derivative) @ $0EDGAR
2024-01-094EyePoint Pharmaceuticals, Inc. (EYPT)Option exercise (M): 15,285 @ $0 · Tax withholding (F): 4,487 @ $20.40 · Grant/award (A): 21,000 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0 · Option exercise (M): 15,285 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1574261 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →